FDA researchers found that Singulair, sold generically as montelukast, attaches to brain receptors critical to psychiatric ...

AstraZeneca has ended work on an opioid use disorder (OUD) drug after the orexin 1 receptor antagonist demonstrated a ...

U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co may be linked to ...

Popular weight loss drugs like Ozempic and Wegovy are showing incredible short-term benefits – from boosted metabolic health ...

The team includes researchers from the Institute for Neurosciences (IN), a joint center of the Miguel Hernández University of ...

TCR immunotherapy is emerging as a promising, targeted approach for treating solid tumours and other indications.

The researchers found that the drug, sold under brand name Singulair and generically as montelukast, attaches to multiple brain receptors critical to psychiatric functioning. Don't Miss our Black ...

A Reuters report on Friday revealed that FDA researchers have found additional molecular evidence tying blockbuster asthma therapy montelukast to adverse neuropsychiatric effects.

A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions ...

A widely used asthma therapy first marketed by Merck (NYSE:MRK) may be associated with severe mental issues, including suicidal thoughts, for some patients, Reuters reported Friday, citing a ...

Brimonidine 0.33% gel and oxymetazoline 1% cream typically start working within 30-60 minutes, according to Julie C. Harper.